These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12464122)

  • 1. The therapeutic challenges in the older Parkinson's disease patient.
    Playfer JR
    Eur J Neurol; 2002 Nov; 9 Suppl 3():55-8. PubMed ID: 12464122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WHOQOL-OLD assessment of quality of life in elderly patients with Parkinson's disease: influence of sleep and depressive symptoms.
    Margis R; Donis KC; Schönwald SV; Rieder CR
    Braz J Psychiatry; 2010 Jun; 32(2):125-31. PubMed ID: 20428729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive rehabilitation for Parkinson’s disease dementia: a study protocol for a pilot randomised controlled trial.
    Hindle JV; Watermeyer TJ; Roberts J; Martyr A; Lloyd-Williams H; Brand A; Gutting P; Hoare Z; Edwards RT; Clare L
    Trials; 2016 Mar; 17():152. PubMed ID: 27000036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interdisciplinary Home Visits for Individuals with Advanced Parkinson's Disease and Related Disorders.
    Fleisher J; Barbosa W; Sweeney MM; Oyler SE; Lemen AC; Fazl A; Ko M; Meisel T; Friede N; Dacpano G; Gilbert RM; Di Rocco A; Chodosh J
    J Am Geriatr Soc; 2018 Jul; 66(6):1226-1232. PubMed ID: 29608779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quadruple Decision Making for Parkinson's Disease Patients: Combining Expert Opinion, Patient Preferences, Scientific Evidence, and Big Data Approaches to Reach Precision Medicine.
    van den Heuvel L; Dorsey RR; Prainsack B; Post B; Stiggelbout AM; Meinders MJ; Bloem BR
    J Parkinsons Dis; 2020; 10(1):223-231. PubMed ID: 31561387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study.
    Aarsland D; Larsen JP; Tandberg E; Laake K
    J Am Geriatr Soc; 2000 Aug; 48(8):938-42. PubMed ID: 10968298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated multidisciplinary care in Parkinson's disease: a non-randomised, controlled trial (IMPACT).
    van der Marck MA; Munneke M; Mulleners W; Hoogerwaard EM; Borm GF; Overeem S; Bloem BR;
    Lancet Neurol; 2013 Oct; 12(10):947-56. PubMed ID: 23988337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Descriptive study and pharmacotherapeutic intervention in patients with epilepsy or Parkinson's disease at nursing homes in southern Sweden.
    Midlöv P; Bondesson A; Eriksson T; Petersson J; Minthon L; Höglund P
    Eur J Clin Pharmacol; 2002 Feb; 57(12):903-10. PubMed ID: 11936711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Problem solving care models for Parkinson's disease].
    Csóka M; Molnár S; Kellős É; Domján G
    Orv Hetil; 2016 May; 157(22):855-68. PubMed ID: 27211355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New horizons in Parkinson's disease in older populations.
    Chhetri JK; Mei S; Wang C; Chan P
    Age Ageing; 2023 Oct; 52(10):. PubMed ID: 37847793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Parkinson's Disease 20 Years from Now: Towards Digital Health Pathways.
    Klucken J; Krüger R; Schmidt P; Bloem BR
    J Parkinsons Dis; 2018; 8(s1):S85-S94. PubMed ID: 30584171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Geriatric particularities of Parkinson's disease: Clinical and therapeutic aspects].
    Belin J; Houéto JL; Constans T; Hommet C; de Toffol B; Mondon K
    Rev Neurol (Paris); 2015 Dec; 171(12):841-52. PubMed ID: 26573332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life of patients with Parkinson's disease and neurodegenerative dementia: A nationally representative study.
    Chekani F; Bali V; Aparasu RR
    Res Social Adm Pharm; 2016; 12(4):604-13. PubMed ID: 26508270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment interventions for Parkinson's disease: an evidence based assessment.
    Rascol O; Goetz C; Koller W; Poewe W; Sampaio C
    Lancet; 2002 May; 359(9317):1589-98. PubMed ID: 12047983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new tool to adapt the treatment of Parkinson's disease patients in nursing homes.
    Geny C; Verna C; Arifi A; Ferreira E; Boubakri C; Blain H
    Geriatr Psychol Neuropsychiatr Vieil; 2018 Mar; 16(1):106-111. PubMed ID: 29569562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of hallucinations and delusions in Parkinson's disease.
    Holroyd S; Currie L; Wooten GF
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):734-8. PubMed ID: 11385005
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.